While every In Vitro Diagnostics brand journey, mission and merchandise are different, the regulatory compliance…

While every In Vitro Diagnostics brand journey, mission and merchandise are different, the regulatory compliance…
In February 2022, Obelis Group acquires SYNC Projects and expands its operations to the Israeli market, securing compliance in a new territory.
The bans will affect not only new products but also cosmetics already on shelves on the EU market that will need to be withdrawn.
Don’t miss this unique opportunity to learn suggested strategies and best practices that lead to successful IVDR transition and outcomes!
According to Regulation (EU) 2021/1099 dated July 5, 2021, Deoxyarbutin has been added to the list of substances prohibited for use in cosmetics. At the same time, some restrictions have been imposed on the use of Dihydroxyacetone. Read our article to know more details!
In this webinar, we will be providing you with information about the UK MHRA Medical Devices & IVDs registration process registration
For the 6th year consecutively the European cosmetics Responsible Person Association (ERPA) is organizing the annual Congress on Regulations and Compliance for Cosmetics. Want to know more? Visit our page!
We met with over 400 manufacturers from more than 50 countries in MEDICA’s halls. Here are the latest news and insights we got from medical manufacturers.
In this webinar, we will provide an overview of the role of the Responsible Person in UK and the notification process
The European Commission published two draft adequacy decisions for the UK in relation on personal data protection. Check out the article for in-depth information!